Dana Holding Corporation Common Stock, par value $0.01 per share Underwriting Agreement
Exhibit 1.2
Xxxx Holding Corporation
Common Stock, par value $0.01 per share
September 23, 2009
Xxxxxxx, Sachs & Co.,
As representative of the several Underwriters
named in Schedule I hereto (the “Representative”),
00 Xxxxx Xxxxxx,
Xxx Xxxx, Xxx Xxxx 00000.
As representative of the several Underwriters
named in Schedule I hereto (the “Representative”),
00 Xxxxx Xxxxxx,
Xxx Xxxx, Xxx Xxxx 00000.
Ladies and Gentlemen:
Xxxx Holding Corporation, a Delaware corporation (the “Company”), proposes, subject to the
terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I
hereto (the “Underwriters”) an aggregate of 34,000,000 shares (the “Firm Shares”) and, at the
election of the Underwriters, up to 5,100,000 additional shares (the “Optional Shares”) of Common
Stock, par value $0.01 per share (“Stock”) of the Company (the Firm Shares and the Optional Shares
that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the
“Shares”).
1. The Company represents and warrants to, and agrees with, each of the Underwriters that:
(a) A registration statement on Form S-3 (File No. 333-161676) (the “Initial
Registration Statement”) in respect of the Shares has been filed with the Securities and
Exchange Commission (the “Commission”); the Initial Registration Statement and any
post-effective amendment thereto, each in the form heretofore delivered to you and,
excluding exhibits to the Initial Registration Statement, but including all documents
incorporated by reference in the prospectus included therein, to you for each of the other
Underwriters have been declared effective by the Commission in such form; no other document
with respect to the Initial Registration Statement or document incorporated by reference
therein has heretofore been filed, or transmitted for filing, with the Commission (other
than prospectuses filed pursuant to Rule 424(b) of the rules and regulations of the
Commission under the Securities Act of 1933, as amended (the “Act”), each in the form
heretofore delivered to you); and no stop order suspending the effectiveness of the Initial
Registration Statement, any post-effective amendment thereto or any part thereof, has been
issued and no proceeding for that purpose has been initiated or threatened by the Commission
(the base prospectus filed as part of the Initial Registration Statement, in the form in
which it has most
recently been filed with the Commission on or prior to the date of this Agreement
relating to the Shares, is hereinafter called the “Basic Prospectus”; any preliminary
prospectus (including any preliminary prospectus supplement) relating to the Shares filed
with the Commission pursuant to Rule 424(b) under the Act is hereinafter called a
“Preliminary Prospectus”; the various parts of the Initial Registration Statement, including
all exhibits thereto and including any prospectus supplement relating to the Shares that is
filed with the Commission and deemed by virtue of Rule 430B under the Act to be part of the
Initial Registration Statement, each as amended at the time such part of the Initial
Registration Statement became effective, are hereinafter collectively called the
“Registration Statement”; the Basic Prospectus, as amended and supplemented immediately
prior to the Applicable Time (as defined in Section 1(c) hereof), is hereinafter called the
“Pricing Prospectus”; the form of the final prospectus relating to the Shares filed with
Commission pursuant to Rule 424(b) under the Act in accordance with Section 5(a) hereof is
hereinafter called the “Prospectus”; any reference herein to the Basic Prospectus, the
Pricing Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to
and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3,
as of the date of such prospectus; any reference to any amendment or supplement to the Basic
Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and
include any post-effective amendment to the Registration Statement, any prospectus
supplement relating to the Shares filed with the Commission pursuant to Rule 424(b) under
the Act and any documents filed under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and incorporated therein, in each case after the date of the Basic
Prospectus, such Preliminary Prospectus or the Prospectus, as the case may be; any reference
to any amendment to the Registration Statement shall be deemed to refer to and include any
annual report of the Company filed pursuant to Section 13(a) or 15(d) of the Exchange Act
after the effective date of the Registration Statement that is incorporated by reference in
the Registration Statement; and any “issuer free writing prospectus” as defined in Rule 433
under the Act relating to the Shares is hereinafter called an “Issuer Free Writing
Prospectus”);
(b) No order preventing or suspending the use of any Preliminary Prospectus or any
Issuer Free Writing Prospectus has been issued by the Commission, and each Preliminary
Prospectus, at the time of filing thereof, conformed in all material respects to the
requirements of the Act and the rules and regulations of the Commission thereunder, and did
not contain an untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; provided, however, that this
representation and warranty shall not apply to any statements or omissions made in reliance
upon and in conformity with information furnished in writing to the Company by an
Underwriter through Xxxxxxx, Sachs & Co. expressly for use therein;
(c) For the purposes of this Agreement, the “Applicable Time” is 5:00 p.m. (Eastern
time) on the date of this Agreement. The Pricing Prospectus, as of the
2
Applicable Time, did not include any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading; and each Issuer Free Writing
Prospectus listed on Schedule II(a) hereto does not conflict with the information contained
in the Registration Statement, the Pricing Prospectus or the Prospectus and each such Issuer
Free Writing Prospectus, as supplemented by and taken together with the Pricing Prospectus
as of the Applicable Time, did not include any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading; provided, however, that
this representation and warranty shall not apply to statements or omissions made in an
Issuer Free Writing Prospectus in reliance upon and in conformity with information furnished
in writing to the Company by an Underwriter through Xxxxxxx, Xxxxx & Co. expressly for use
therein;
(d) The documents incorporated by reference in the Pricing Prospectus and Prospectus,
when they became effective or were filed with the Commission, as the case may be, conformed
in all material respects to the requirements of the Act or the Exchange Act, as applicable,
and the rules and regulations of the Commission thereunder, and none of such documents
contained an untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary to make the statements therein not misleading;
and any further documents so filed and incorporated by reference in the Prospectus or any
further amendment or supplement thereto, when such documents become effective or are filed
with the Commission, as the case may be, will conform in all material respects to the
requirements of the Act or the Exchange Act, as applicable, and the rules and regulations of
the Commission thereunder and will not contain an untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading; provided, however, that this representation and warranty
shall not apply to any statements or omissions made in reliance upon and in conformity with
information furnished in writing to the Company by an Underwriter through Xxxxxxx, Sachs &
Co. expressly for use therein; and no such documents were filed with the Commission since
the Commission’s close of business on the business day immediately prior to the date of this
Agreement and prior to the execution of this Agreement, except as set forth on Schedule
II(b) hereto;
(e) The Registration Statement conforms, and the Prospectus and any further amendments
or supplements to the Registration Statement and the Prospectus will conform, in all
material respects to the requirements of the Act and the rules and regulations of the
Commission thereunder and do not and will not, as of the applicable effective date as to
each part of the Registration Statement and as of the applicable filing date as to the
Prospectus and any amendment or supplement thereto, contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading; provided, however, that this representation and
warranty shall not apply to any statements or
3
omissions made in reliance upon and in conformity with information furnished in writing
to the Company by an Underwriter through Xxxxxxx, Xxxxx & Co. expressly for use therein;
(f) Neither the Company nor any of its “significant subsidiaries” (as such term is
defined in Rule 1-02(w) of Regulation S-X under the Act) has sustained since the date of the
latest audited financial statements included or incorporated by reference in the Pricing
Prospectus any loss or interference with its business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor dispute or court or
governmental action, order or decree, otherwise than as set forth or contemplated in the
Pricing Prospectus and except as would not, individually or in the aggregate, have a
material adverse effect on the current or future consolidated financial position,
stockholders’ equity or results of operations of the Company and its subsidiaries, taken as
a whole (a “Material Adverse Effect”); and, since the respective dates as of which
information is given in the Registration Statement and the Pricing Prospectus, there has not
been any change in the capital stock (except for changes pursuant to the Company’s equity
plans described in its filings under the Exchange Act and incorporated by reference into the
Pricing Prospectus and changes due to the exercise of options outstanding prior to the date
of this Agreement) or long term debt of the Company or any of its subsidiaries or any
material adverse change, or any development involving a prospective material adverse change,
in or affecting the general affairs, management, financial position, stockholders’ equity or
results of operations of the Company and its subsidiaries, taken as a whole, otherwise than
as set forth or contemplated in the Pricing Prospectus;
(g) The Company and its significant subsidiaries have good and valid title in fee
simple to all real property and good and valid title to all personal property owned by them,
in each case free and clear of all liens, encumbrances and defects except such as are
described in the Pricing Prospectus or such as do not materially affect the value of such
property and do not materially interfere with the use made and proposed to be made of such
property by the Company and its subsidiaries; and any real property and buildings held under
lease by the Company and its significant subsidiaries are held by them under valid,
subsisting and enforceable leases with such exceptions as are not material and do not
materially interfere with the use made and proposed to be made of such property and
buildings by the Company and such subsidiaries;
(h) The Company has been duly incorporated and is validly existing as a corporation in
good standing under the laws of the State of Delaware, with power and authority (corporate
and other) to own its properties and conduct its business as described in the Pricing
Prospectus, and has been duly qualified as a foreign corporation for the transaction of
business and is in good standing under the laws of each other jurisdiction in which it owns
or leases properties or conducts any business so as to require such qualification, except to
the extent that the failure to be so qualified or in good standing in any such jurisdiction
would not have a Material Adverse Effect; and each significant subsidiary of the Company has
been duly
4
incorporated and is validly existing as a corporation in good standing under the laws
of its jurisdiction of incorporation;
(i) The Company has an authorized capitalization as set forth in the Pricing Prospectus
and all of the issued shares of capital stock of the Company have been duly and validly
authorized and issued and are fully paid and non-assessable and conform to the description
of the Stock contained in the Pricing Prospectus and Prospectus; and all of the issued
shares of capital stock of each significant subsidiary of the Company have been duly and
validly authorized and issued, are fully paid and non-assessable and (except for directors’
qualifying shares and other minority interests disclosed to you) are owned directly or
indirectly by the Company, free and clear of all liens, encumbrances, equities or claims;
(j) The Shares to be issued and sold by the Company to the Underwriters hereunder have
been duly authorized and, when issued and delivered against payment therefor as provided
herein, will be duly and validly issued and fully paid and non-assessable and will conform
to the description thereof in the Pricing Prospectus;
(k) The issue and sale of the Shares and the compliance by the Company with this
Agreement and the consummation of the transactions herein contemplated will not conflict
with or result in a breach or violation of any of the terms or provisions of, or constitute
a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement
or instrument to which the Company or any of its subsidiaries is a party or by which the
Company or any of its subsidiaries is bound or to which any of the property or assets of the
Company or any of its subsidiaries is subject, nor will such action result in any violation
of the provisions of the Restated Certificate of Incorporation or By-laws of the Company or
any statute or any order, rule or regulation of any court or governmental agency or body
having jurisdiction over the Company or any of its subsidiaries or any of their properties;
and no consent, approval, authorization, order, registration or qualification of or with any
such court or governmental agency or body is required for the issue and sale of the Shares
or the consummation by the Company of the transactions contemplated by this Agreement except
such as have been obtained under the Act and such consents, approvals, authorizations,
registrations or qualifications as may be required under state securities or Blue Sky laws
in connection with the purchase and distribution of the Shares by the Underwriters;
(l) Other than as set forth in the Pricing Prospectus, there are no legal or
governmental proceedings pending to which the Company or any of its subsidiaries is a party
or of which any property of the Company or any of its subsidiaries is the subject, which, if
determined adversely to the Company or any of its subsidiaries, would have a Material
Adverse Effect; and, to the best of the Company’s knowledge, no such proceedings are
threatened or contemplated by governmental authorities or threatened by others;
(m) Neither the Company nor any of its significant subsidiaries is in violation of its
Certificate of Incorporation or By-laws or in default in the performance or
5
observance of any material obligation, covenant or condition contained in any
indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument
to which it is a party or by which it or any of its properties may be bound, except such as
would not have a Material Adverse Effect;
(n) The statements set forth in the Pricing Prospectus and Prospectus under the caption
“Description of Capital Stock”, insofar as they purport to constitute a summary of the terms
of the Stock, and under the caption “Certain United States Federal Income Tax Consequences
to Non-U.S. Holders”, insofar as they purport to describe the provisions of the laws and
documents referred to therein, are accurate, complete and fair in all material respects;
(o) The Company is not and, after giving effect to the offering and sale of the Shares
and the application of the proceeds thereof, will not be an “investment company”, as such
term is defined in the Investment Company Act of 1940, as amended (the “Investment Company
Act”);
(p) At the earliest time after the filing of the Initial Registration Statement that
the Company or another offering participant made a bona fide offer (within the meaning of
Rule 164(h)(2) under the Act) of the Shares, the Company was not an “ineligible issuer” as
defined in Rule 405 under the Act;
(q) PricewaterhouseCoopers LLP, who have certified certain financial statements of the
Company and its subsidiaries, and have audited the Company’s internal control over financial
reporting and reviewed management’s assessment thereof, is an independent registered public
accounting firm as required by the Act and the rules and regulations of the Commission
thereunder;
(r) The Company maintains a system of internal control over financial reporting (as
such term is defined in Rule 13a-15(f) under the Exchange Act) that complies with the
requirements of the Exchange Act and has been designed by the Company’s principal executive
officer and principal financial officer, or under their supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles. The Company’s internal control over financial reporting is effective and the
Company is not aware of any material weaknesses in its internal control over financial
reporting;
(s) Since the date of the latest audited financial statements included or incorporated
by reference in the Prospectus, there has been no change in the Company’s internal control
over financial reporting that has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial reporting;
(t) The Company maintains disclosure controls and procedures (as such term is defined
in Rule 13a-15(e) under the Exchange Act) that comply with the
6
requirements of the Exchange Act; such disclosure controls and procedures have been
designed to ensure that material information relating to the Company and its subsidiaries is
made known to the Company’s principal executive officer and principal financial officer by
others within those entities; and such disclosure controls and procedures are effective;
(u) Except as disclosed in the Pricing Prospectus, neither the Company nor any of its
subsidiaries (i) is in violation of any law, statute, or any rule, regulation, decision or
order of any governmental agency or body or any court relating to the use, disposal or
release of hazardous or toxic substances or relating to the protection or restoration of the
environment or human exposure to hazardous or toxic substances (collectively, “Environmental
Laws”), (ii) owns or operates any real property which, to its knowledge, is contaminated
with any substance that is regulated under any Environmental Laws, (iii) is, to its
knowledge, liable for any off-site disposal or contamination pursuant to any Environmental
Laws, or (iv) has received any written notice of any claim under any Environmental Laws, and
the Company is not aware of any pending investigation which could reasonably be expected to
lead to such a claim, in the case of clauses (i), (ii), (iii) and (iv), which could have,
individually or in the aggregate, a Material Adverse Effect;
(v) To the Company’s knowledge, the Company and each of its subsidiaries own, possess
or have the right to employ sufficient patents, patent rights, licenses, inventions,
copyrights, know how (including trade secrets and other unpatented and/or unpatentable
proprietary or confidential information, software, systems or procedures), trademarks,
service marks and trade names, inventions, computer programs, technical data and information
(collectively, the “Intellectual Property Rights”) reasonably necessary to conduct their
businesses as now conducted, except where the failure to own, possess or have the right
would not, individually or in the aggregate, have a Material Adverse Effect. Neither the
Company nor any of its subsidiaries has received any notice of infringement or conflict with
asserted rights of others with respect to any of the Intellectual Property Rights, whether
or not arising from transactions in the ordinary course of business, except for such
infringements or conflicts that would not, individually or in the aggregate, have a Material
Adverse Effect. To the Company’s knowledge, the use of the Intellectual Property Rights in
connection with the business and operations of the Company and its subsidiaries does not
infringe on the rights of any person, except to the extent that any such infringement would
not reasonably be expected to result in a Material Adverse Effect;
(w) The Company and each of its subsidiaries are insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as are, in
management’s judgment, prudent and customary in the businesses in which they are engaged;
neither the Company nor any such subsidiary has been refused any insurance coverage sought
or applied for; and neither the Company nor any such subsidiary has any reason to believe
that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage
7
from similar insurers as may be necessary to continue its business at a cost that would
not, have a Material Adverse Effect, except, in each case, as set forth in or contemplated
in the Pricing Prospectus; and
(x) As of the date hereof, to the best of the Company’s knowledge, none of the
Company’s debt securities (for the avoidance of doubt, excluding any debt under the
Company’s term loan facility or revolving credit facility) or preferred stock has been rated
by any “nationally recognized statistical rating organization”, as that term is defined by
the Commission for purposes of Rule 436(g)(2) under the Act.
2. Subject to the terms and conditions herein set forth, (a) the Company agrees to issue and
sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly,
to purchase from the Company, at a purchase price per share of $6.4092, the number of Firm Shares
set forth opposite the name of such Underwriter in Schedule I hereto and (b) in the event and to
the extent that the Underwriters shall exercise the election to purchase Optional Shares as
provided below, the Company agrees to issue and sell to each of the Underwriters, and each of the
Underwriters agrees, severally and not jointly, to purchase from the Company, at the purchase price
per share set forth in clause (a) of this Section 2, that portion of the number of Optional Shares
as to which such election shall have been exercised (to be adjusted by you so as to eliminate
fractional shares) determined by multiplying such number of Optional Shares by a fraction, the
numerator of which is the maximum number of Optional Shares which such Underwriter is entitled to
purchase as set forth opposite the name of such Underwriter in Schedule I hereto and the
denominator of which is the maximum number of Optional Shares that all of the Underwriters are
entitled to purchase hereunder.
The Company hereby grants to the Underwriters the right to purchase at their election up to
5,100,000 Optional Shares, at the purchase price per share set forth in the paragraph above, for
the sole purpose of covering sales of shares in excess of the number of Firm Shares, provided that
the purchase price per Optional Share shall be reduced by an amount per share equal to any
dividends or distributions declared by the Company and payable on the Firm Shares but not payable
on the Optional Shares. Any such election to purchase Optional Shares may be exercised only by
written notice from you to the Company, given within a period of 30 calendar days after the date of
this Agreement, setting forth the aggregate number of Optional Shares to be purchased and the date
on which such Optional Shares are to be delivered, as determined by you but in no event earlier
than the First Time of Delivery (as defined in Section 4 hereof) or, unless you and the Company
otherwise agree in writing, earlier than two or later than ten business days after the date of such
notice.
3. Upon the authorization by you of the release of the Firm Shares, the several Underwriters
propose to offer the Firm Shares for sale upon the terms and conditions set forth in the
Prospectus.
4. (a) The Shares to be purchased by each Underwriter hereunder, in definitive global form,
and in such authorized denominations and registered in such names as Xxxxxxx, Sachs & Co. may
request upon at least forty-eight hours’ prior notice to the
8
Company shall be delivered by or on behalf of the Company to Xxxxxxx, Xxxxx & Co., through the
facilities of the Depository Trust Company (“DTC”), for the account of such Underwriter, against
payment by or on behalf of such Underwriter of the purchase price therefor by wire transfer of
Federal (same-day) funds to the account specified by the Company to Xxxxxxx, Sachs & Co. at least
forty-eight hours in advance. The Company will cause the certificates representing the Shares to
be made available for checking and packaging at least twenty-four hours prior to the Time of
Delivery (as defined below) with respect thereto at the office of DTC or its designated custodian
(the “Designated Office”). The time and date of such delivery and payment shall be, with respect
to the Firm Shares, 9:30 a.m., New York City time, on September 29, 2009 or such other time and
date as Xxxxxxx, Xxxxx & Co. and the Company may agree upon in writing, and, with respect to the
Optional Shares, 9:30 a.m., New York time, on the date specified by Xxxxxxx, Sachs & Co. in the
written notice given by Xxxxxxx, Xxxxx & Co. of the Underwriters’ election to purchase such
Optional Shares, or such other time and date as Xxxxxxx, Sachs & Co. and the Company may agree upon
in writing. Such time and date for delivery of the Firm Shares is herein called the “First Time of
Delivery”, such time and date for delivery of the Optional Shares, if not the First Time of
Delivery, is herein called the “Second Time of Delivery”, and each such time and date for delivery
is herein called a “Time of Delivery”.
(b) The documents to be delivered at each Time of Delivery by or on behalf of the parties
hereto pursuant to Section 8 hereof, including the cross receipt for the Shares and any additional
documents requested by the Underwriters pursuant to Section 8(j) hereof, will be delivered at the
offices of Xxxxxxxx & Xxxxxxxx LLP, 000 Xxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 (the “Closing
Location”), and the Shares will be delivered at the Designated Office, all at such Time of
Delivery. A meeting will be held at the Closing Location at 5:00 p.m., New York City time, on the
New York Business Day next preceding such Time of Delivery, at which meeting the final drafts of
the documents to be delivered pursuant to the preceding sentence will be available for review by
the parties hereto. For the purposes of this Section 4, “New York Business Day” shall mean each
Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in
New York are generally authorized or obligated by law or executive order to close.
5. The Company agrees with each of the Underwriters:
(a) To prepare the Prospectus in a form approved by you and to file such Prospectus
pursuant to Rule 424(b) under the Act not later than the Commission’s close of business on
the second business day following the date of this Agreement or such earlier time as may be
required under the Act; to make no further amendment or any supplement to the Registration
Statement, the Basic Prospectus or the Prospectus prior to the last Time of Delivery which
shall be disapproved by you promptly after reasonable notice thereof; to advise you,
promptly after it receives notice thereof, of the time when any amendment to the
Registration Statement has been filed or becomes effective or any amendment or supplement to
the Prospectus has been filed and to furnish you with copies thereof; to file promptly all
material required to be filed by the Company with the Commission pursuant to Rule 433(d)
under the Act; within the time required by such Rule; to file
promptly all reports and any definitive proxy or
9
information statements required to be filed by the Company with
the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent
to the date of the Prospectus and for so long as the delivery of a prospectus (or in lieu
thereof, the notice referred to in Rule 173(a) under the Act) is required in connection with
the offering or sale of the Shares; to advise you, promptly after it receives notice
thereof, of the issuance by the Commission of any stop order or of any order preventing or
suspending the use of any Preliminary Prospectus or other prospectus in respect of the
Shares, of the suspension of the qualification of the Shares for offering or sale in any
jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of
any request by the Commission for the amending or supplementing of the Registration
Statement or the Prospectus or for additional information; and, in the event of the issuance
of any stop order or of any order preventing or suspending the use of any Preliminary
Prospectus or other prospectus or suspending any such qualification, to promptly use its
best efforts to obtain the withdrawal of such order;
(b) Promptly from time to time to take such action as you may reasonably request to
qualify the Shares for offering and sale under the securities laws of such jurisdictions as
you may request and to comply with such laws so as to permit the continuance of sales and
dealings therein in such jurisdictions for as long as may be necessary to complete the
distribution of the Shares, provided that in connection therewith the Company shall not be
required to qualify as a foreign corporation or to take any action that would subject it to
general service of process in any jurisdiction or subject it to taxation as a foreign
corporation;
(c) Prior to 10:00 a.m., New York City time, on the New York Business Day next
succeeding the date of this Agreement and from time to time, to furnish the Underwriters
with electronic copies of the Prospectus in New York City (and with printed copies of the
Prospectus by 10:00 a.m. in the following New York Business Day), and, if the delivery of a
prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) is
required at any time prior to the expiration of nine months after the time of issue of the
Prospectus in connection with the offering or sale of the Shares and if at such time any
event shall have occurred as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made when such Prospectus (or in lieu thereof, the
notice referred to in Rule 173(a) under the Act) is delivered, not misleading, or, if for
any other reason it shall be necessary during such same period to amend or supplement the
Prospectus or to file under the Exchange Act any document incorporated by reference in the
Prospectus in order to comply with the Act or the Exchange Act, to notify you and upon your
request to file such document and to prepare and furnish without charge to each Underwriter
and to any dealer in securities as many written and electronic copies as you may from time
to time reasonably request of an amended Prospectus or a supplement to the Prospectus which
will correct such statement or omission or effect such compliance; and in case any Underwriter is required to deliver a prospectus (or in lieu thereof,
the
10
notice referred to in Rule 173(a) under the Act) in connection with sales of any of the
Shares at any time nine months or more after the time of issue of the Prospectus, upon your
request but at the expense of such Underwriter, to prepare and deliver to such Underwriter
as many written and electronic copies as you may request of an amended or supplemented
Prospectus complying with Section 10(a)(3) of the Act;
(d) To make generally available to its security holders as soon as practicable, but in
any event not later than sixteen months after the effective date of the Registration
Statement (as defined in Rule 158(c) under the Act), an earnings statement of the Company
and its subsidiaries (which need not be audited) complying with Section 11(a) of the Act and
the rules and regulations of the Commission thereunder (including, at the option of the
Company, Rule 158);
(e) During the period beginning from the date hereof and continuing to and including
the date 90 days after the date of the Prospectus, not to offer, sell, contract to sell,
pledge, grant any option to purchase, make any short sale or otherwise dispose, except as
provided hereunder, of any securities of the Company that are substantially similar to the
Shares, including but not limited to any options or warrants to purchase shares of Stock or
any securities that are convertible into or exchangeable for, or that represent the right to
receive, Stock or any such substantially similar securities (other than pursuant to employee
stock option plans existing on, or upon the conversion or exchange of convertible or
exchangeable securities outstanding as of, the date of this Agreement), without your prior
written consent;
(f) Upon request of any Underwriter, to furnish, or cause to be furnished, to such
Underwriter an electronic version of the Company’s trademarks, servicemarks and corporate
logo for use on the website, if any, operated by such Underwriter for the purpose of
facilitating the on-line offering of the Shares (the “License”); provided, however, that the
License shall be used solely for the purpose described above, is granted without any fee and
may not be assigned or transferred;
(g) To use the net proceeds received by it from the sale of the Shares in the manner
specified in the Pricing Prospectus under the caption “Use of Proceeds”; and
(h) To use its commercially reasonable efforts to list, subject to notice of issuance,
the Shares on the New York Stock Exchange (the “Exchange”).
6. (a) The Company represents and agrees that, without the prior consent of Xxxxxxx, Xxxxx &
Co., it has not made and will not make any offer relating to the Securities that would constitute a
“free writing prospectus” as defined in Rule 405 under the Act; each Underwriter represents and
agrees that, without the prior consent of the Company and Xxxxxxx, Sachs & Co., it has not made and
will not make any offer relating to the Securities that would constitute a free writing prospectus;
any such free writing prospectus the use of which has been consented to by the Company and Xxxxxxx,
Xxxxx & Co. is listed on
Schedule II(a) hereto;
11
(b) The Company has complied and will comply with the requirements of Rule 433 under the Act
applicable to any Issuer Free Writing Prospectus, including timely filing with the Commission or
retention where required and legending; and
(c) The Company agrees that if at any time following issuance of an Issuer Free Writing
Prospectus any event occurred or occurs as a result of which such Issuer Free Writing Prospectus
would conflict with the information in the Registration Statement, the Pricing Prospectus or the
Prospectus or would include an untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances then
prevailing, not misleading, the Company will give prompt notice thereof to Xxxxxxx, Sachs & Co.
and, if requested by Xxxxxxx, Xxxxx & Co., will prepare and furnish without charge to each
Underwriter an Issuer Free Writing Prospectus or other document which will correct such conflict,
statement or omission; provided, however, that this obligation shall not apply to any statements or
omissions in an Issuer Free Writing Prospectus made in reliance upon and in conformity with
information furnished in writing to the Company by an Underwriter through Xxxxxxx, Sachs & Co.
expressly for use therein.
7. The Company covenants and agrees with the several Underwriters that the Company will pay or
cause to be paid the following: (i) the fees, disbursements and expenses of the Company’s counsel
and accountants in connection with the registration of the Shares under the Act and all other
expenses in connection with the preparation, printing, reproduction and filing of the Registration
Statement, the Basic Prospectus, any Preliminary Prospectus, any Issuer Free Writing Prospectus and
the Prospectus and amendments and supplements thereto and the mailing and delivering of copies
thereof to the Underwriters and dealers; (ii) the cost of printing or producing any Agreement among
Underwriters, this Agreement, any Blue Sky Memorandum, closing documents (including any
compilations thereof) and any other documents in connection with the offering, purchase, sale and
delivery of the Shares; (iii) all expenses in connection with the qualification of the Shares for
offering and sale under state securities laws as provided in Section 5(b) hereof, including the
fees and disbursements of counsel for the Underwriters in connection with such qualification and in
connection with the Blue Sky survey(s); (iv) any filing fees incident to, and the fees and
disbursements of counsel for the Underwriters in connection with, any required reviews by the
Financial Industry Regulatory Authority (“FINRA”) of the terms of the sale of the Shares; (v) the
cost of preparing certificates for the Shares; (vi) the cost and charges of any transfer agent or
registrar or dividend disbursing agent; (vii) all fees and expenses in connection with listing the
Shares on the Exchange; and (viii) all other costs and expenses incident to the performance of its
obligations hereunder which are not otherwise specifically provided for in this Section. It is
understood, however, that, except as provided in this Section, and Sections 9 and 12 hereof, the
Underwriters will pay all of their own costs and expenses, including the fees of their counsel,
transfer taxes on resale of any of the Shares by them, and any advertising expenses connected with
any offers they may make.
12
8. The obligations of the Underwriters hereunder, as to the Shares to be delivered at each
Time of Delivery, shall be subject, in their discretion, to the condition that all representations
and warranties and other statements of the Company herein are, at and as of such Time of Delivery,
true and correct, the condition that the Company shall have performed all of its obligations
hereunder theretofore to be performed, and the following additional conditions:
(a) The Prospectus shall have been filed with the Commission pursuant to Rule 424(b)
under the Act within the applicable time period prescribed for such filing by the rules and
regulations under the Act and in accordance with Section 5(a) hereof; all material required
to be filed by the Company pursuant to Rule 433(d) under the Act shall have been filed with
the Commission within the applicable time period prescribed for such filings by Rule 433; no
stop order suspending the effectiveness of the Registration Statement or any part thereof
shall have been issued and no proceeding for that purpose shall have been initiated or
threatened by the Commission; no stop order suspending or preventing the use of the
Prospectus or any Issuer Free Writing Prospectus shall have been initiated or threatened by
the Commission; and all requests for additional information on the part of the Commission
shall have been complied with to your reasonable satisfaction;
(b) Xxxxxxxx & Xxxxxxxx LLP, counsel for the Underwriters, shall have furnished to you
such written opinion or opinions, dated such Time of Delivery, in form and substance
satisfactory to you, and such counsel shall have received such papers and information as
they may reasonably request to enable them to pass upon such matters;
(c) (1) Xxxx, Weiss, Rifkind, Xxxxxxx & Xxxxxxxx LLP, counsel for the Company, shall
have furnished to you their written opinion or opinions, dated such Time of Delivery, in
form and substance satisfactory to you, to the effect set forth in Annex II hereto; and (2)
Xxxxxx X. Xxxxxxx, Xx., Senior Counsel for the Company, shall have furnished to you his
written opinion or opinions, dated such Time of Delivery, in form and substance satisfactory
to you and to the effect set forth in Annex III hereto;
(d) On the date of the Prospectus at a time prior to the execution of this Agreement,
at 9:30 a.m., New York City time, on the effective date of any post effective amendment to
the Registration Statement filed subsequent to the date of this Agreement and also at each
Time of Delivery, PricewaterhouseCoopers LLP shall have furnished to you a letter or
letters, dated the respective dates of delivery thereof, in form and substance satisfactory
to you, to the effect set forth in Annex I hereto (the executed copy of the letter delivered
prior to the execution of this Agreement is attached as Annex I(a) hereto and a form of
letter to be delivered on the effective date of any post-effective amendment to the
Registration Statement, and as of the Time of Delivery is attached as Annex I(b) hereto);
(e) (i) Neither the Company nor any of its subsidiaries shall have sustained since the
date of the latest audited financial statements included or incorporated by
13
reference in the Pricing Prospectus any loss or interference with its business from
fire, explosion, flood or other calamity, whether or not covered by insurance, or from any
labor dispute or court or governmental action, order or decree, otherwise than as set forth
or contemplated in the Pricing Prospectus, and (ii) since the respective dates as of which
information is given in the Pricing Prospectus there shall not have been any change in the
capital stock or long-term debt of the Company or any of its subsidiaries or any change, or
any development involving a prospective change, in or affecting the general affairs,
management, financial position, stockholders’ equity or results of operations of the Company
and its subsidiaries, otherwise than as set forth or contemplated in the Pricing Prospectus,
the effect of which, in any such case described in clause (i) or (ii), is in your judgment
so material and adverse as to make it impracticable or inadvisable to proceed with the
public offering or the delivery of the Shares on the terms and in the manner contemplated in
the Prospectus;
(f) On or after the Applicable Time there shall not have occurred any of the following:
(i) a suspension or material limitation in trading in securities generally on the Exchange;
(ii) a suspension or material limitation in trading in the Company’s securities on the
Exchange; (iii) a general moratorium on commercial banking activities declared by either
Federal or New York State authorities or a material disruption in commercial banking or
securities settlement or clearance services in the United States; (iv) the outbreak or
escalation of hostilities involving the United States or the declaration by the United
States of a national emergency or war or (v) the occurrence of any other calamity or crisis
or any change in financial, political or economic conditions in the United States or
elsewhere; if the effect of any such event specified in clause (iv) or (v) in your judgment
makes it impracticable or inadvisable to proceed with the public offering or the delivery of
the Shares being delivered at such Time of Delivery on the terms and in the manner
contemplated in the Prospectus;
(g) The Shares at each Time of Delivery shall have been duly listed, subject to notice
of issuance, on the Exchange;
(h) The Company shall have complied with the provisions of Section 5(c) hereof with
respect to the furnishing of prospectuses on the New York Business Day next succeeding the
date of this Agreement;
(i) The Company shall have furnished or caused to be furnished to you at such Time of
Delivery certificates of officers of the Company satisfactory to you as to the accuracy of
the representations and warranties of the Company herein at and as of such Time of Delivery,
as to the performance by the Company of all of its obligations hereunder to be performed at
or prior to such Time of Delivery, as to the matters set forth in subsections (a) and (e) of
this Section and as to such other matters as you may reasonably request; and
(j) The Company shall have obtained and delivered to the Underwriters executed copies
of an agreement from the parties listed on Schedule III hereto, in the form attached as
Annex III hereto.
14
9. (a) The Company will indemnify and hold harmless each Underwriter against any losses,
claims, damages or liabilities, joint or several, to which such Underwriter may become subject,
under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of
a material fact contained in the Registration Statement, the Basic Prospectus, any Preliminary
Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, any
Issuer Free Writing Prospectus or any “issuer information” filed or required to be filed pursuant
to Rule 433(d) under the Act, or arise out of or are based upon the omission or alleged omission to
state therein a material fact required to be stated therein or necessary to make the statements
therein not misleading, and will reimburse each Underwriter for any legal or other expenses
reasonably incurred by such Underwriter, provided that in no event shall the Company be responsible
for the costs and expenses of more than one separate legal counsel (in addition to any local
counsel) pursuant to subsection (c) below, in connection with investigating or defending any such
action or claim as such expenses are incurred; provided, however, that the Company shall not be
liable in any such case to the extent that any such loss, claim, damage or liability arises out of
or is based upon an untrue statement or alleged untrue statement or omission or alleged omission
made in the Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the Pricing
Prospectus or the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing
Prospectus, in reliance upon and in conformity with written information furnished to the Company by
any Underwriter through Xxxxxxx, Xxxxx & Co. expressly for use therein.
(b) Each Underwriter will indemnify and hold harmless the Company against any losses, claims,
damages or liabilities to which the Company may become subject, under the Act or otherwise, insofar
as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are
based upon an untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the Pricing Prospectus or
the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus, or
arise out of or are based upon the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein not misleading, in each
case to the extent, but only to the extent, that such untrue statement or alleged untrue statement
or omission or alleged omission was made in the Registration Statement, the Basic Prospectus, any
Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement
thereto, or any Issuer Free Writing Prospectus, in reliance upon and in conformity with written
information furnished to the Company by such Underwriter through Xxxxxxx, Sachs & Co. expressly for
use therein; and will reimburse the Company for any legal or other expenses reasonably incurred by
the Company in connection with investigating or defending any such action or claim as such expenses
are incurred.
(c) Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice
of the commencement of any action, such indemnified party shall, if a claim in respect thereof is
to be made against the indemnifying party under such subsection, notify the indemnifying party in
writing of the commencement thereof; failure by such indemnified
15
party to so notify the indemnifying party shall relieve the indemnifying party of the
obligation to indemnify the indemnified party under such subsection only to the extent that the
indemnifying party suffers actual prejudice as a result of such failure, but shall not relieve the
indemnifying party from any liability which it may have to any indemnified party otherwise than
under such subsection. In case any such action shall be brought against any indemnified party and
it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be
entitled to participate therein and, to the extent that it shall wish, jointly with any other
indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably
satisfactory to such indemnified party (who shall not, except with the consent of the indemnified
party, be counsel to the indemnifying party), and, after notice from the indemnifying party to such
indemnified party of its election so to assume the defense thereof, the indemnifying party shall
not be liable to such indemnified party under such subsection for any legal expenses of other
counsel or any other expenses, in each case subsequently incurred by such indemnified party, in
connection with the defense thereof other than reasonable costs of investigation. No indemnifying
party shall, without the written consent of the indemnified party, effect the settlement or
compromise of, or consent to the entry of any judgment with respect to, any pending or threatened
action or claim in respect of which indemnification or contribution may be sought hereunder
(whether or not the indemnified party is an actual or potential party to such action or claim)
unless such settlement, compromise or judgment (i) includes an unconditional release of the
indemnified party from all liability arising out of such action or claim and (ii) does not include
any statement as to or an admission of fault, culpability or a failure to act, by or on behalf of
any indemnified party.
(d) If the indemnification provided for in this Section 9 is unavailable to or insufficient to
hold harmless an indemnified party under subsection (a) or (b) above in respect of any losses,
claims, damages or liabilities (or actions in respect thereof) referred to therein, then each
indemnifying party shall contribute to the amount paid or payable by such indemnified party as a
result of such losses, claims, damages or liabilities (or actions in respect thereof) in such
proportion as is appropriate to reflect the relative benefits received by the Company on the one
hand and the Underwriters on the other from the offering of the Shares. If, however, the
allocation provided by the immediately preceding sentence is not permitted by applicable law or if
the indemnified party failed to give the notice required under subsection (c) above, then each
indemnifying party shall contribute to such amount paid or payable by such indemnified party in
such proportion as is appropriate to reflect not only such relative benefits but also the relative
fault of the Company on the one hand and the Underwriters on the other in connection with the
statements or omissions which resulted in such losses, claims, damages or liabilities (or actions
in respect thereof), as well as any other relevant equitable considerations. The relative benefits
received by the Company on the one hand and the Underwriters on the other shall be deemed to be in
the same proportion as the total net proceeds from the offering (before deducting expenses)
received by the Company bear to the total underwriting discounts and commissions received by the
Underwriters, in each case as set forth in the table on the cover page of the Prospectus. The
relative fault shall be determined by reference to, among other things, whether the untrue or
alleged untrue
16
statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company on the one hand or the Underwriters on the other and
the parties’ relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission. The Company and the Underwriters agree that it would not be
just and equitable if contribution pursuant to this subsection (d) were determined by pro rata
allocation (even if the Underwriters were treated as one entity for such purpose) or by any other
method of allocation which does not take account of the equitable considerations referred to above
in this subsection (d). The amount paid or payable by an indemnified party as a result of the
losses, claims, damages or liabilities (or actions in respect thereof) referred to above in this
subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such
indemnified party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this subsection (d), no Underwriter shall be required to
contribute any amount in excess of the amount by which the total price at which the Shares
underwritten by it and distributed to the public were offered to the public exceeds the amount of
any damages which such Underwriter has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. The
Underwriters’ obligations in this subsection (d) to contribute are several in proportion to their
respective underwriting obligations and not joint.
(e) The obligations of the Company under this Section 9 shall be in addition to any liability
which the Company may otherwise have and shall extend, upon the same terms and conditions, to each
person, if any, who controls any Underwriter within the meaning of the Act and each broker-dealer
affiliate of any Underwriter; and the obligations of the Underwriters under this Section 9 shall be
in addition to any liability which the respective Underwriters may otherwise have and shall extend,
upon the same terms and conditions, to each officer and director of the Company and to each person,
if any, who controls the Company within the meaning of the Act.
10. (a) If any Underwriter shall default in its obligation to purchase the Shares which it
has agreed to purchase hereunder at a Time of Delivery, you may in your discretion arrange for you
or another party or other parties to purchase such Shares on the terms contained herein. If within
thirty six hours after such default by any Underwriter you do not arrange for the purchase of such
Shares, then the Company shall be entitled to a further period of thirty six hours within which to
procure another party or other parties satisfactory to you to purchase such Shares on such terms.
In the event that, within the respective prescribed periods, you notify the Company that you have
so arranged for the purchase of such Shares, or the Company notifies you that it has so arranged
for the purchase of such Shares, you or the Company shall have the right to postpone such Time of
Delivery for a period of not more than seven days, in order to effect whatever changes may thereby
be made necessary in the Registration Statement or the Prospectus, or in any other documents or
arrangements, and the Company agrees to file promptly any amendments or supplements to the
Registration Statement or the Prospectus which in your opinion may
thereby be made necessary. The term “Underwriter” as used in this Agreement shall include any person
17
substituted under this Section with like effect as if such person had originally been a party to
this Agreement with respect to such Shares.
(b) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting
Underwriter or Underwriters by you and the Company as provided in subsection (a) above, the
aggregate number of such Shares which remains unpurchased does not exceed one-eleventh of the
aggregate number of all the Shares to be purchased at such Time of Delivery, then the Company shall
have the right to require each non-defaulting Underwriter to purchase the number of shares which
such Underwriter agreed to purchase hereunder at such Time of Delivery and, in addition, to require
each non-defaulting Underwriter to purchase its pro rata share (based on the number of Shares which
such Underwriter agreed to purchase hereunder) of the Shares of such defaulting Underwriter or
Underwriters for which such arrangements have not been made; but nothing herein shall relieve a
defaulting Underwriter from liability for its default.
(c) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting
Underwriter or Underwriters by you and the Company as provided in subsection (a) above, the
aggregate number of such Shares which remains unpurchased exceeds one-eleventh of the aggregate
number of all the Shares to be purchased at such Time of Delivery, or if the Company shall not
exercise the right described in subsection (b) above to require non-defaulting Underwriters to
purchase Shares of a defaulting Underwriter or Underwriters, then this Agreement (or, with respect
to the Second Time of Delivery, the obligations of the Underwriters to purchase and of the Company
to sell the Optional Shares) shall thereupon terminate, without liability on the part of any
non-defaulting Underwriter or the Company, except for the expenses to be borne by the Company and
the Underwriters as provided in Section 7 hereof and the indemnity and contribution agreements in
Section 9 hereof; but nothing herein shall relieve a defaulting Underwriter from liability for its
default.
11. The respective indemnities, agreements, representations, warranties and other statements
of the Company and the several Underwriters, as set forth in this Agreement or made by or on behalf
of them, respectively, pursuant to this Agreement, shall remain in full force and effect,
regardless of any investigation (or any statement as to the results thereof) made by or on behalf
of any Underwriter or any controlling person of any Underwriter, or the Company, or any officer or
director or controlling person of the Company, and shall survive delivery of and payment for the
Shares.
12. If this Agreement shall be terminated pursuant to Section 10 hereof, the Company shall not
then be under any liability to any Underwriter except as provided in Sections 7 and 9 hereof; but,
if for any other reason, any Shares are not delivered by or on behalf of the Company as provided
herein, the Company will reimburse the Underwriters through you for all out-of-pocket expenses
approved in writing by you, including fees and disbursements of counsel, reasonably incurred by the
Underwriters in making preparations for the purchase, sale and delivery of the Shares not so
delivered, but the Company shall then be under no further liability to any Underwriter except as
provided in Sections 7 and 9 hereof.
18
13. In all dealings hereunder, you shall act on behalf of each of the Underwriters, and the
parties hereto shall be entitled to act and rely upon any statement, request, notice or agreement
on behalf of any Underwriter made or given by you.
All statements, requests, notices and agreements hereunder shall be in writing, and if to the
Underwriters shall be delivered or sent by mail, telex or facsimile transmission to you as the
Representative at 00 Xxxxx Xxxxxx, 00xx Xxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: Registration
Department; and if to the Company shall be delivered or sent by mail, telex or facsimile
transmission to the address of the Company set forth in the Registration Statement, Attention:
Secretary; provided, however, that any notice to an Underwriter pursuant to Section 9(c) hereof
shall be delivered or sent by mail, telex or facsimile transmission to such Underwriter at its
address set forth in its underwriters’ questionnaire, or telex constituting such questionnaire,
which address will be supplied to the Company by you upon request. Any such statements, requests,
notices or agreements shall take effect upon receipt thereof.
In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56
(signed into law October 26, 2001)), the Underwriters are required to obtain, verify and record
information that identifies their respective clients, including the Company, which information may
include the name and address of their respective clients, as well as other information that will
allow the underwriters to properly identify their respective clients.
14. This Agreement shall be binding upon, and inure solely to the benefit of, the
Underwriters, the Company and, to the extent provided in Sections 8 and 10 hereof, the officers and
directors of the Company and each person who controls the Company or any Underwriter, and their
respective heirs, executors, administrators, successors and assigns, and no other person shall
acquire or have any right under or by virtue of this Agreement. No purchaser of any of the Shares
from any Underwriter shall be deemed a successor or assign by reason merely of such purchase.
15. Time shall be of the essence of this Agreement. As used herein, the term “business day”
shall mean any day when the Commission’s office in Washington, D.C. is open for business.
16. The Company acknowledges and agrees that (i) the purchase and sale of the Shares pursuant
to this Agreement is an arm’s-length commercial transaction between the Company, on the one hand,
and the several Underwriters, on the other, (ii) in connection therewith and with the process
leading to such transaction each Underwriter is acting solely as a principal and not the agent or
fiduciary of the Company, (iii) no Underwriter has assumed an advisory or fiduciary responsibility
in favor of the Company with respect to the offering contemplated hereby or the process leading
thereto (irrespective of whether such Underwriter has advised or is currently advising the Company
on other matters) or any other obligation to the Company except the obligations expressly set forth
in this Agreement and (iv) the Company has consulted its own legal and financial advisors to the
extent it deemed appropriate. The Company agrees that it will not claim that the Underwriters, or
any of them,
19
has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty
to the Company, in connection with such transaction or the process leading thereto.
17. This Agreement supersedes all prior agreements and understandings (whether written or
oral) between the Company and the Underwriters, or any of them, with respect to the subject matter
hereof.
18. THIS AGREEMENT AND ANY MATTERS RELATED TO THIS TRANSACTION SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF
CONFLICT OF LAWS THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAWS OF THE STATE
OF NEW YORK. The Company agrees that any suit or proceeding arising in respect of this agreement
or our engagement will be tried exclusively in the U.S. District Court for the Southern District of
New York or, if that court does not have subject matter jurisdiction, in any state court located in
The City and County of New York and the Company agrees to submit to the jurisdiction of, and to
venue in, such courts.
19. The Company and each of the Underwriters hereby irrevocably waives, to the fullest
extent permitted by applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby.
20. Notwithstanding anything herein to the contrary, the Company is authorized to disclose to
any persons U.S. federal and state tax treatment and tax structure of the potential transaction and
all materials of any kind (including tax opinions and other tax analyses) provided to the Company
relating to that treatment and structure, without the Underwriters imposing any limitation of any
kind. However, any information relating to the tax treatment and tax structure shall remain
confidential (and the foregoing sentence shall not apply) to the extent necessary to enable any
person to comply with securities laws. For this purpose, “tax structure” is limited to any facts
that may be relevant to that treatment.”
20
If the foregoing is in accordance with your understanding, please sign and return to us four
counterparts hereof, and upon the acceptance hereof by you, on behalf of each of the Underwriters,
this letter and such acceptance hereof shall constitute a binding agreement between each of the
Underwriters and the Company. It is understood that your acceptance of this letter on behalf of
each of the Underwriters is pursuant to the authority set forth in a form of Agreement among
Underwriters, the form of which shall be submitted to the Company for examination upon request, but
without warranty on your part as to the authority of the signers thereof.
Very truly yours, Xxxx Holding Corporation |
||||
By: | /s/ Xxxxx X. Xxxx | |||
Name: | Xxxxx X. Xxxx | |||
Title: | EVP & CFO | |||
Accepted as of the date hereof: Xxxxxxx, Sachs & Co. |
||||
/s/ Xxxxxxx, Xxxxx & Co. | ||||
(Xxxxxxx, Sachs & Co.) | ||||
On behalf of each of the Underwriters | ||||
21
SCHEDULE I
Maximum | ||||||||
Number | ||||||||
Number of | of Optional | |||||||
Firm Shares | Shares Which | |||||||
to be | May be | |||||||
Underwriter | Purchased | Purchased | ||||||
Xxxxxxx, Xxxxx & Co. |
20,461,200 | 3,069,180 | ||||||
Citigroup Capital Markets Inc. |
3,760,400 | 564,060 | ||||||
X.X. Xxxxxx Securities Inc. |
3,760,400 | 564,060 | ||||||
Deutsche Bank Securities Inc. |
2,257,600 | 338,640 | ||||||
UBS Securities LLC |
2,257,600 | 338,640 | ||||||
Barclays Capital Inc. |
1,502,800 | 225,420 | ||||||
Total |
34,000,000 | 5,100,000 | ||||||
22
SCHEDULE II
(a) | Issuer Free Writing Prospectuses not included in the Pricing Prospectus: | |
Electronic roadshow posted on xxxxxxxxxxx.xxx on September 21, 2009. | ||
(b) | Additional Documents Incorporated by Reference: | |
None. |
SCHEDULE III
Lock-up Signatories:
1. Xxxxx Xxxxxx
2. Xxxxxx Xxxxxx
3. Xxxxxx Xxxxxxxx
4. Xxxx Xxxxxx
5. Xxxxxxxxxx Xxxx
6. Xxxx Xxxxxx
7. Xxxxxxx Xxxx
8. Xxxxxx Xxxxxx
9. Xxxx Xxxxxxxx
10. Xxxx Xxxxxxx
11. Xxxxxxxx Xxxxxxx
12. Xxxx Xxxxx
13. Xxxxxx Xxxxxx
14. Xxxx Xxxxxx
15. Xxxx Xxxxxxx
16. Xxxxx Xxxxxxxx
17. Xxxxx Than
18. Xxxxxxx Xxxxx
19. Xxxxx Xxxxxxx
20. Xxxx Xxxxxxx
21. Xxxxx Xxxxxxx
22. Xxxxx Xxxx
23. Xxxxx Xxxx
2. Xxxxxx Xxxxxx
3. Xxxxxx Xxxxxxxx
4. Xxxx Xxxxxx
5. Xxxxxxxxxx Xxxx
6. Xxxx Xxxxxx
7. Xxxxxxx Xxxx
8. Xxxxxx Xxxxxx
9. Xxxx Xxxxxxxx
10. Xxxx Xxxxxxx
11. Xxxxxxxx Xxxxxxx
12. Xxxx Xxxxx
13. Xxxxxx Xxxxxx
14. Xxxx Xxxxxx
15. Xxxx Xxxxxxx
16. Xxxxx Xxxxxxxx
17. Xxxxx Than
18. Xxxxxxx Xxxxx
19. Xxxxx Xxxxxxx
20. Xxxx Xxxxxxx
21. Xxxxx Xxxxxxx
22. Xxxxx Xxxx
23. Xxxxx Xxxx
ANNEX I
Form of comfort letter pursuant to Section 8(d)
ANNEX II
Form of opinion and letter of Xxxx, Weiss, Rifkind, Xxxxxxx & Xxxxxxxx LLP pursuant to Section
8(c)(1):
A. Form of Opinion
1. The Company has been duly incorporated and is validly existing and in good standing under
the laws of the State of Delaware. The Company has all necessary corporate power and authority to
execute, deliver and perform its obligations under the Underwriting Agreement and to own and hold
its properties and conduct its business as described in the Prospectus.
2. The Shares have been duly authorized by all necessary corporate action on the part of the
Company and, when issued and delivered to and paid for by the Underwriters in accordance with the
terms of the Underwriting Agreement, will be validly issued, fully paid and non-assessable.
3. The common stock, par value $0.01 per share, of the Company conforms in all material
respects to the description contained in the Pricing Disclosure Package and the Prospectus under
the caption “Description of Capital Stock.”
4. The Underwriting Agreement has been duly authorized, executed and delivered by the Company.
5. The statements in the Prospectus under the heading “Certain United States Federal Income
Tax Consequences to Non-U.S. Holders,” to the extent that they constitute summaries of United
States federal law or regulation or legal conclusions, have been reviewed by us and fairly
summarize the matters described under that heading in all material respects.
6. The Registration Statement and the Prospectus, as of their respective effective or issue
times, appear on their face to be appropriately responsive in all material respects to the
requirements of the Act and the rules and regulations of the Commission under the Act (the “Rules
and Regulations”), except for the financial statements, financial statement schedules and other
financial data included or incorporated by reference in or omitted from either of them and the
Forms T-1, as to which we express no opinion.
7. We do not know of any contract or other document which is required to be filed as an
exhibit to the Registration Statement by the Act or the Rules and Regulations and which has not
been so filed or incorporated by reference as an exhibit to the Registration Statement as permitted
by the Rules and Regulations.
8. The issuance and sale of the Shares by the Company, the compliance by the Company with all
of the provisions of the Underwriting Agreement and the performance by the Company of its
obligations thereunder will not (i) result in a violation of the Charter Documents, (ii) breach or
result in a default under any agreement, indenture or instrument listed on Schedule II hereto or
(iii) violate Applicable Law or any judgment, order or decree of any court or arbitrator known to
us, except, in the case of clauses (ii) and (iii) above, where
the breach, default or violation could not reasonably be expected to have a material adverse effect
on the Company and its subsidiaries taken as a whole. For purposes of this letter, the term
“Applicable Law” means the General Corporation Law of the State of Delaware (the “GCL”) and those
laws, rules and regulations of the United States of America and the State of New York, in each case
which in our experience are normally applicable to the transactions of the type contemplated by the
Underwriting Agreement, except that “Applicable Law” does not include the anti-fraud provisions of
the securities laws of any applicable jurisdiction, any state securities or Blue Sky laws or the
rules and regulations of the Financial Industry Regulatory Authority.
9. No consent, approval, authorization or order of, or filing, registration or qualification
with, any Governmental Authority, that has not been obtained, taken or made is required by the
Company under any Applicable Law for the issuance or sale of the Shares or the performance by the
Company of its obligations under the Underwriting Agreement. For purposes of this letter, the term
“Governmental Authority” means any executive, legislative, judicial, administrative or regulatory
body of the State of New York, the State of Delaware or the United States of America.
10. The Company is not and, after giving effect to the offering and sale of the Shares and the
application of their proceeds as described in the Prospectus under the heading “Use of Proceeds,”
will not be required to be registered as an investment company under the Investment Company Act of
1940, as amended, and the rules and regulations of the Commission promulgated thereunder.
B. Form of Letter
1. In the course of acting as counsel to the Company in connection with the offering of the
Shares, we have participated in conferences and telephone conversations with officers and other
representatives of the Company, the independent registered public accountants for the Company, and
representatives of, and legal counsel to, the Underwriters, during which conferences and
conversations the contents of the Registration Statement, the Pricing Disclosure Package, the
Prospectus and related matters were discussed. Based upon such participation (and relying as to
materiality with respect to factual matters to the extent we deemed reasonable on officers,
employees and other representatives of the Company), our understanding of the U.S. federal
securities laws and the experience we have gained in our practice thereunder, we hereby advise you
that our work in connection with this matter did not disclose any information that gave us reason
to believe that (i) as of its effective date, the Registration Statement (except for the financial
statements, financial statement schedules and other financial data included or incorporated by
reference therein or omitted therefrom or from those documents incorporated by reference and the
Forms T-1, in each case, as to which we express no such belief), included an untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary to
make the statements therein not misleading; (ii) as of the Applicable Time (as defined in the
Underwriting Agreement), the Pricing Disclosure Package (except for the financial statements,
financial statement schedules and other financial data included or incorporated
by reference therein or omitted therefrom or from those documents incorporated by reference, as to
which we express no such belief) included an untrue statement of a material fact or omitted to
state a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; or (iii) at the time the Prospectus was
issued and as of the date hereof, the Prospectus (except for the financial statements, financial
statement schedules and other financial data included or incorporated by reference therein or
omitted therefrom or from those documents incorporated by reference, as to which we express no such
belief) included an untrue statement of a material fact or omitted to state a material fact
necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading.
2. In this opinion, (i) such Registration Statement at the time it became effective under the
Act, including the documents incorporated by reference therein and the information deemed to be
part of the Registration Statement under Rule 430B under the Act, is referred to as the
“Registration Statement,” (ii) the base prospectus dated September 17, 2009, included as part of
the Registration Statement, including the documents incorporated by reference therein, is referred
to as the “Base Prospectus,” (iii) the Base Prospectus, as supplemented by the preliminary
prospectus supplement dated September 21, 2009 relating to the Shares, including the documents
incorporated by reference therein, taken together with the number of Shares and the price of the
Shares to the public and the related underwriting discounts and commissions, as of September 23,
2009, is referred to as the “Pricing Disclosure Package” and (iv) the Base Prospectus, as
supplemented by the final prospectus supplement dated September 23, 2009, including the documents
incorporated by reference therein, is referred to as the “Prospectus.”
ANNEX III
Form of opinion of Xxxxxx X. Xxxxxxx, Xx., Senior Counsel for the Company, pursuant to Section
8(c)(2):
1. The Company has an authorized capitalization as set forth in the Prospectus, and all of the
issued shares of capital stock of the Company (including the Shares being delivered at such Time of
Delivery) have been duly and validly authorized and issued and are fully paid and non-assessable
and the Shares conform to the description of the Shares in the Prospectus; and the statements set
forth in the Prospectus under the caption “Description of Capital Stock”, insofar as they purport
to constitute a summary of the terms of the Stock are accurate, complete and fair;
2. The Company has been duly qualified as a foreign corporation for the transaction of
business and is in good standing under the laws of each other jurisdiction in which it owns or
leases properties or conducts any business so as to require such qualification, or is subject to no
material liability or disability by reason of the failure to be so qualified in any such
jurisdiction;
3. Each significant subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X
under the Securities Act of 1933, as amended) of the Company has been duly incorporated and is
validly existing as a corporation in good standing under the laws of its jurisdiction of
incorporation; and all of the issued shares of capital stock of each such subsidiary have been duly
and validly authorized and issued, are fully paid and non-assessable, and (except for directors’
qualifying shares) are owned directly or indirectly by the Company, free and clear of all liens,
encumbrances, equities or claims;
4. To my knowledge and other than as set forth in the Prospectus, there are no legal or
governmental proceedings pending to which the Company or any of its significant subsidiaries is a
party or of which any property of the Company or any of its significant subsidiaries is the subject
which, if determined adversely to the Company or any of its significant subsidiaries, would
individually or in the aggregate have a Material Adverse Effect; and to such counsel’s knowledge,
no such proceedings are threatened or contemplated by governmental authorities or threatened by
others;
5. The issue and sale of the Shares being delivered at the Time of Delivery and the compliance
by the Company with the Underwriting Agreement and the consummation of the transactions herein
contemplated will not conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument known to me to which the Company or any of its
subsidiaries is a party or by which the Company or any of its significant subsidiaries is bound or
to which any of the property or assets of the Company or any of its significant subsidiaries is
subject, nor will such actions result in any violation of the provisions of the Certificate of
Incorporation or By-laws of the Company or any statute or any order, rule or regulation known to me
of any court or governmental agency or body having jurisdiction over the Company or any of its
subsidiaries or any of their properties;
6. Neither the Company nor any of its significant subsidiaries is in violation of its
Certificate of Incorporation or By-laws or in default in the performance or observance of any
material obligation, agreement, covenant or condition contained in any indenture, mortgage, deed of
trust, loan agreement, lease or other agreement or instrument to which it is a party or by which it
or any of its properties may be bound; and
7. I do not know of any amendment to the Registration Statement required to be filed or of any
contracts or other documents of a character required to be filed as an exhibit to the Registration
Statement or required to be incorporated by reference into the Prospectus or required to be
described in the Registration Statement, the Basic Prospectus or the Prospectus which are not filed
or incorporated by reference or described as required.